BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 14, 2025; 31(34): 110611
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.110611
Imaging in perianal fistulising Crohn’s disease: A practical guide for the gastroenterologist
Habeeb Habeeb, Lynna Chen, Isabelle De Kock, Gauraang Bhatnagar, Numan Kutaiba, Abhinav Vasudevan, Ashish R Srinivasan
Habeeb Habeeb, Lynna Chen, Abhinav Vasudevan, Ashish R Srinivasan, Department of Gastroenterology, Eastern Health, Box Hill 3128, Victoria, Australia
Lynna Chen, Abhinav Vasudevan, Ashish R Srinivasan, Eastern Clinical School, Monash University, Melbourne 3128, Victoria, Australia
Isabelle De Kock, Department of Radiology and Medical Imaging, Ghent University Hospital, Ghent 9000, Belgium
Gauraang Bhatnagar, Department of Radiology, Frimley Health NHS Trust, Frimley GU16 7UJ, Surrey, United Kingdom
Gauraang Bhatnagar, Centre for Medical Imaging, University College London, London WC1E 6BT, United Kingdom
Numan Kutaiba, Department of Radiology, Austin Health, Heidelberg 3084, Victoria, Australia
Ashish R Srinivasan, Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne 3084, Victoria, Australia
Co-first authors: Habeeb Habeeb and Lynna Chen.
Co-corresponding authors: Abhinav Vasudevan and Ashish R Srinivasan.
Author contributions: Habeeb H and Chen L contributed equally to this work as co-first authors; Srinivasan AR contributed to study concept and design; Srinivasan AR and Vasudevan A contributed to supervision and contributed equally to this work as co-corresponding authors; Habeeb H, Chen L, and Srinivasan AR contributed to drafting of manuscript; Srinivasan AR, Vasudevan A, Kutaiba N, De Kock I, and Bhatnagar G contributed to critical review of manuscript. All authors approved the final draft prior to submission.
Conflict-of-interest statement: Dr. Vasudevan reports personal fees from Ferring, Abbvie, and Pfizer, outside the submitted work.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ashish R Srinivasan, PhD, Adjunct Associate Professor, FRACP, Department of Gastroenterology, Eastern Health, 8 Arnold Street, Box Hill 3128, Victoria, Australia. ashish.srinivasan@monash.edu
Received: June 11, 2025
Revised: July 3, 2025
Accepted: August 13, 2025
Published online: September 14, 2025
Processing time: 87 Days and 2.3 Hours
Abstract

Perianal fistulising Crohn’s disease is a challenging complication that can affect up to 20% of patients with Crohn’s disease and is associated with significant morbidity. Despite advances in medical therapies, particularly anti-tumor necrosis factor agents, the majority of patients still require surgical intervention. Accurate diagnosis and monitoring are essential to optimise outcomes and guide multidisciplinary management. Although clinical scoring systems such as the perianal disease activity index are widely used, their subjective application limits their reproducibility and reliability, underscoring the need for more objective methods of evaluating perianal fistulising Crohn’s disease activity. Imaging has thus become central to the objective assessment of perianal fistulising Crohn’s disease, with magnetic resonance imaging (MRI) recognised as the gold standard in view of its ability to provide clear, detailed images of the perianal region in a radiation-free manner. Guidelines also endorse the use of imaging modalities such as endoanal ultrasound and transperineal ultrasound as viable alternatives to MRI for the assessment of perianal fistulising Crohn’s disease in centres with appropriate expertise. This article aims to evaluate and compare the diagnostic accuracy and clinical utility of MRI, endoanal ultrasound, and transperineal ultrasound in the assessment of perianal fistulising Crohn’s disease, highlighting their respective strengths, limitations, and roles in clinical practice.

Keywords: Crohn’s disease; Perianal; Fistulising; Imaging; Magnetic resonance imaging; Ultrasound

Core Tip: Perianal fistulising Crohn’s disease affects up to 20% of patients and frequently requires combined medical and surgical management. Accurate and objective disease assessment is essential for the diagnosis, monitoring, and guidance of therapeutic interventions. Magnetic resonance imaging of the pelvis is the gold standard imaging modality for the evaluation of perianal fistulising Crohn’s disease. However, modalities such as endoanal ultrasound and transperineal ultrasound represent practical and accessible alternatives, particularly for repeated short to medium-term disease reassessment. This article aims to evaluate and compare the diagnostic accuracy and clinical utility of magnetic resonance imaging, endoanal ultrasound, and transperineal ultrasound in the assessment of perianal fistulising Crohn’s disease.